Evidence map›Paper›PMID 40403232›Full record

ArticlePloS one2025

A design-based framework for optimal stratification using super-population models with application on real data set of breast cancer.

Faizan Danish

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Faizan DanishDepartment of Mathematics, School of Advanced Sciences, VIT-AP University, Inavolu, Beside AP Secretariat, Amaravati, Andhra Pradesh, India.ORCID 0000-0002-0476-9744

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates the determination of stratification points for two study variables within the framework of simple random sampling, with a focus on estimating the population mean using a closely related auxiliary variable. Employing a superpopulation model, the research aims to minimize overall variance by deriving simplified equations that enhance the precision of parameter estimates. Instead of categorizing variables, the study emphasizes continuous variables to establish optimal strata boundaries (OSB), which are essential for creating homogeneous groups within each stratum. This stratification leads to more efficient sample sizes (SS) and improved accuracy in parameter estimation. However, achieving optimal OSB and SS poses challenges in scenarios with a fixed total sample size, such as survey designs constrained by limited budgets. To address this, the study proposes a robust methodology for calculating OSB and SS, leveraging knowledge of the survey's per-unit stratum measurement costs or its probability density function. An empirical application of the method is demonstrated using breast cancer data, where the mean perimeter is estimated based on mean radius and mean texture. Additionally, hypothetical examples using Cauchy and standard power distributions are provided to illustrate the versatility of the proposed approach. The newly developed method has been integrated into the updated stratifyR package and implemented in LINGO software, facilitating its practical application. Comparative analysis reveals that this approach consistently outperforms or matches existing methods in enhancing the precision of population parameter estimation. Furthermore, simulation studies confirm its higher relative efficiency, making it a valuable contribution to the field of stratified sampling.

Indexed as

Breast NeoplasmsModels, StatisticalComputer SimulationFemaleHumansSample Size

Identifiers

PMID40403232
PMCPMC12097798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.